Effects of neuropeptide FF system on CB 1 and CB 2 receptors mediated antinociception in mice

Neuropharmacology

Volumn 62, Issue 2, 2012, Pages 855-864

  Fang, Quan ^a   Han, Zheng Lan ^a   Li, Ning ^a   Wang, Zi Long ^a   He, Ning ^a   Wang, Rui ^a,b  

^a LANZHOU UNIVERSITY   (China)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Antinociception; Cannabinoid; Mice; Neuropeptide FF (NPFF); WIN55,212 2

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; NEUROPEPTIDE FF;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANALGESIA; ANALGESICS; ANIMALS; BENZOXAZINES; INDOLES; MALE; MICE; MORPHOLINES; NALOXONE; NAPHTHALENES; OLIGOPEPTIDES; PAIN; PAIN MEASUREMENT; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2;

EID: 84855930166     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.09.013     Document Type: Article

References (55)

1. K. Benamar, E.B. Geller, and M.W. Adler First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain J. Pharmacol. Exp. Ther. 325 2008 641 645
2. J.A. Bonini, K.A. Jones, N. Adham, C. Forray, R. Artymyshyn, M.M. Durkin, K.E. Smith, J.A. Tamm, L.W. Boteju, P.P. Lakhlani, R. Raddatz, W.J. Yao, K.L. Ogozalek, N. Boyle, E.V. Kouranova, Y. Quan, P.J. Vaysse, J.M. Wetzel, T.A. Branchek, C. Gerald, and B. Borowsky Identification and characterization of two G protein-coupled receptors for neuropeptide FF J. Biol. Chem. 275 2000 39324 39331
3. I. Bushlin, R. Rozenfeld, and L.A. Devi Cannabinoid-opioid interactions during neuropathic pain and analgesia Curr. Opin. Pharmacol. 10 2010 80 86
4. X. Chen, F. Bing, P. Dai, and Y. Hong Involvement of protein kinase C in 5-HT-evoked thermal hyperalgesia and spinal fos protein expression in the rat Pharmacol. Biochem. Behav. 84 2006 8 16
5. J.P. Chhatwal, A.R. Gutman, K.A. Maguschak, M.E. Bowser, Y. Yang, M. Davis, and K.J. Ressler Functional interactions between endocannabinoid and CCK neurotransmitter systems may be critical for extinction learning Neuropsychopharmacology 34 2009 509 521
6. D.L. Cichewicz Synergistic interactions between cannabinoid and opioid analgesics Life Sci. 74 2004 1317 1324
7. J. Corchero, M.A. Avila, J.A. Fuentes, and J. Manzanares delta-9-Tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat Life Sci. 61 1997 PL 39 PL 43
8. N.A. Elshourbagy, R.S. Ames, L.R. Fitzgerald, J.J. Foley, J.K. Chambers, P.G. Szekeres, N.A. Evans, D.B. Schmidt, P.T. Buckley, G.M. Dytko, P.R. Murdock, G. Milligan, D.A. Groarke, K.B. Tan, U. Shabon, P. Nuthulaganti, D.Y. Wang, S. Wilson, D.J. Bergsma, and H.M. Sarau Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor J. Biol. Chem. 275 2000 25965 25971
9. Q. Fang, J. Guo, F. He, Y.L. Peng, M. Chang, and R. Wang In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist Peptides 27 2006 2207 2213
10. Q. Fang, T.N. Jiang, N. Li, Z.L. Han, and R. Wang Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice Protein Pept. Lett. 18 2011 403 409
11. Q. Fang, Y.Q. Wang, F. He, J. Guo, J. Guo, Q. Chen, and R. Wang Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist Regul. Pept. 147 2008 45 51
12. S.R. George, T. Fan, Z. Xie, R. Tse, V. Tam, G. Varghese, and B.F. O'Dowd Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties J. Biol. Chem. 275 2000 26128 26135
13. S. Gicquel, J. Fioramonti, L. Bueno, and J.M. Zajac Effects of F8Famide analogs on intestinal transit in mice Peptides 14 1993 749 753
14. C. Gouarderes, H. Mazarguil, C. Mollereau, N. Chartrel, J. Leprince, H. Vaudry, and J.M. Zajac Functional differences between NPFF1 and NPFF2 receptor coupling: high intrinsic activities of RFamide-related peptides on stimulation of [35S]GTPgammaS binding Neuropharmacology 52 2007 376 386
15. L.M. Harrison, A.J. Kastin, and J.E. Zadina Opiate tolerance and dependence: receptors, G-proteins, and antiopiates Peptides 19 1998 1603 1630
16. S. Hinuma, Y. Shintani, S. Fukusumi, N. Iijima, Y. Matsumoto, M. Hosoya, R. Fujii, T. Watanabe, K. Kikuchi, Y. Terao, T. Yano, T. Yamamoto, Y. Kawamata, Y. Habata, M. Asada, C. Kitada, T. Kurokawa, H. Onda, O. Nishimura, M. Tanaka, Y. Ibata, and M. Fujino New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals Nat. Cell Biol. 2 2000 703 708
17. M.M. Ibrahim, F. Porreca, J. Lai, P.J. Albrecht, F.L. Rice, A. Khodorova, G. Davar, A. Makriyannis, T.W. Vanderah, H.P. Mata, and T.P. Malan Jr. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids Proc. Natl. Acad. Sci. U S A 102 2005 3093 3098
18. M.M. Ibrahim, M.L. Rude, N.J. Stagg, H.P. Mata, J. Lai, T.W. Vanderah, F. Porreca, N.E. Buckley, A. Makriyannis, and T.P. Malan Jr. CB2 cannabinoid receptor mediation of antinociception Pain 122 2006 36 42
19. F. Kersante, C. Mollereau, J.M. Zajac, and M. Roumy Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model Peptides 27 2006 980 989
20. K. Kurrikoff, J. Inno, T. Matsui, and E. Vasar Stress-induced analgesia in mice: evidence for interaction between endocannabinoids and cholecystokinin Eur. J. Neurosci. 27 2008 2147 2155
21. B.A. Levac, B.F. O'Dowd, and S.R. George Oligomerization of opioid receptors: generation of novel signaling units Curr. Opin. Pharmacol. 2 2002 76 81
22. W. Li, Y.H. Gao, M. Chang, Y.L. Peng, J. Yao, R.W. Han, and R. Wang Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice Peptides 30 2009 234 240
23. Q. Liu, X.M. Guan, W.J. Martin, T.P. McDonald, M.K. Clements, Q. Jiang, Z. Zeng, M. Jacobson, D.L. Williams Jr., H. Yu, D. Bomford, D. Figueroa, J. Mallee, R. Wang, J. Evans, R. Gould, and C.P. Austin Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception J. Biol. Chem. 276 2001 36961 36969
24. T.P. Malan Jr., M.M. Ibrahim, H. Deng, Q. Liu, H.P. Mata, T. Vanderah, F. Porreca, and A. Makriyannis CB2 cannabinoid receptor-mediated peripheral antinociception Pain 93 2001 239 245
25. J. Manzanares, J. Corchero, J. Romero, J.J. Fernandez-Ruiz, J.A. Ramos, and J.A. Fuentes Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain Brain Res. Mol. Brain Res. 55 1998 126 132
26. J. Manzanares, J. Corchero, J. Romero, J.J. Fernandez-Ruiz, J.A. Ramos, and J.A. Fuentes Pharmacological and biochemical interactions between opioids and cannabinoids Trends Pharmacol. Sci. 20 1999 287 294
27. I.D. Meng, B.H. Manning, W.J. Martin, and H.L. Fields An analgesia circuit activated by cannabinoids Nature 395 1998 381 383
28. C. Mollereau, H. Mazarguil, D. Marcus, I. Quelven, M. Kotani, V. Lannoy, Y. Dumont, R. Quirion, M. Detheux, M. Parmentier, and J.M. Zajac Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists Eur. J. Pharmacol. 451 2002 245 256
29. C. Mollereau, H. Mazarguil, J.M. Zajac, and M. Roumy Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells Mol. Pharmacol. 67 2005 965 975
30. C. Mollereau, M. Roumy, and J.M. Zajac Opioid-modulating peptides: mechanisms of action Curr. Top. Med. Chem. 5 2005 341 355
31. L. Mouledous, C. Mollereau, and J.M. Zajac Opioid-modulating properties of the neuropeptide FF system Biofactors 36 2010 423 429
32. D.F. Pacheco, A. Klein, A.C. Perez, C.M. Pacheco, J.N. Francischi, G.M. Reis, and I.D. Duarte Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor Br. J. Pharmacol. 158 2009 225 231
33. D.F. Pacheco, A. Klein, A.G. Perez, C.M.F. Pacheco, J.N. Francischi, and I.D. Duarte The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors Br. J. Pharmacol. 154 2008 1143 1149
34. P. Pacher, S. Batkai, and G. Kunos The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol. Rev. 58 2006 389 462
35. P. Panula, A.A. Aarnisalo, and K. Wasowicz Neuropeptide FF, a mammalian neuropeptide with multiple functions Prog. Neurobiol. 48 1996 461 487
36. P. Panula, E. Kalso, M. Nieminen, V.K. Kontinen, A. Brandt, and A. Pertovaara Neuropeptide FF and modulation of pain Brain Res. 848 1999 191 196
37. S.J. Perry, E. Yi-Kung Huang, D. Cronk, J. Bagust, R. Sharma, R.J. Walker, S. Wilson, and J.F. Burke A human gene encoding morphine modulating peptides related to NPFF and FMRFamide FEBS Lett. 409 1997 426 430
38. R.G. Pertwee Emerging strategies for exploiting cannabinoid receptor agonists as medicines Br. J. Pharmacol. 156 2009 397 411
39. T.A. Pietras, and N.E. Rowland Effect of opioid and cannabinoid receptor antagonism on orphanin FQ-induced hyperphagia in rats Eur. J. Pharmacol. 442 2002 237 239
40. I. Quelven, A. Roussin, and J.M. Zajac Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists Eur. J. Pharmacol. 508 2005 107 114
41. R.B. Raffa, and H.I. Jacoby A-18-famide and F-8-famide, endogenous mammalian equivalents of the molluscan neuropeptide FMRFamide (Phe-Met-Arg-Phe-NH2), inhibit colonic bead expulsion time in mice Peptides 10 1989 873 875
42. S.M. Rawls, J.A. Schroeder, Z. Ding, T. Rodriguez, and N. Zaveri NOP receptor antagonist, JTC-801, blocks cannabinoid-evoked hypothermia in rats Neuropeptides 41 2007 239 247
43. S. Rebeyrolles, J.M. Zajac, and M. Roumy Neuropeptide FF reverses the effect of mu-opioid on Ca2+ channels in rat spinal ganglion neurones Neuroreport 7 1996 2979 2981
44. I. Reche, M. Ruiz-Gayo, and J.A. Fuentes Inhibition of opioid-degrading enzymes potentiates delta9-tetrahydrocannabinol-induced antinociception in mice Neuropharmacology 37 1998 215 222
45. M. Roumy, M. Garnier, and J.M. Zajac Neuropeptide FF receptors 1 and 2 exert an anti-opioid activity in acutely dissociated rat dorsal raphe and periventricular hypothalamic neurones Neurosci. Lett. 348 2003 159 162
46. M. Roumy, C. Lorenzo, S. Mazeres, S. Bouchet, J.M. Zajac, and C. Mollereau Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity J. Biol. Chem. 282 2007 8332 8342
47. M. Roumy, and J.M. Zajac Neuropeptide FF, pain and analgesia Eur. J. Pharmacol. 345 1998 1 11
48. A. Roussin, F. Serre, C. Gouarderes, H. Mazarguil, M. Roumy, C. Mollereau, and J.M. Zajac Anti-analgesia of a selective NPFF2 agonist depends on opioid activity Biochem. Biophys. Res. Commun. 336 2005 197 203
49. F. Simonin, M. Schmitt, J.P. Laulin, E. Laboureyras, J.H. Jhamandas, D. MacTavish, A. Matifas, C. Mollereau, P. Laurent, M. Parmentier, B.L. Kieffer, J.J. Bourguignon, and G. Simonnet RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia Proc. Natl. Acad. Sci. U S A 103 2006 466 471
50. L. Stinus, M. Allard, L. Gold, and G. Simonnet Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment Peptides 16 1995 1235 1241
51. F.S. Vilim, A.A. Aarnisalo, M.L. Nieminen, M. Lintunen, K. Karlstedt, V.K. Kontinen, E. Kalso, B. States, P. Panula, and E. Ziff Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli Mol. Pharmacol. 55 1999 804 811
52. M. Waldhoer, J. Fong, R.M. Jones, M.M. Lunzer, S.K. Sharma, E. Kostenis, P.S. Portoghese, and J.L. Whistler A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers Proc. Natl. Acad. Sci. U S A 102 2005 9050 9055
53. H.Y. Yang, W. Fratta, E.A. Majane, and E. Costa Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine Proc. Natl. Acad. Sci. U S A 82 1985 7757 7761
54. H.Y. Yang, and M.J. Iadarola Modulatory roles of the NPFF system in pain mechanisms at the spinal level Peptides 27 2006 943 952
55. H.Y. Yang, T. Tao, and M.J. Iadarola Modulatory role of neuropeptide FF system in nociception and opiate analgesia Neuropeptides 42 2008 1 18